AYTU vs PRGO

For growth investors, Aytu BioPharma, Inc.

(AYTU) is the stronger pick with 1. 8% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Analysts rate Perrigo Company plc (PRGO) a "Hold" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Perrigo Company plc (PRGO) delivered a total return of -60.

1%, compared to -97. 8% for Aytu BioPharma, Inc. (AYTU). Over 10 years, the gap is even starker: PRGO returned -77. 7% versus AYTU's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Perrigo Company plc (PRGO) is the lower-risk stock at 1.

18β versus Aytu BioPharma, Inc. 's 1. 27β — meaning AYTU is approximately 8% more volatile than PRGO relative to the S&P 500. On balance sheet safety, Aytu BioPharma, Inc. (AYTU) carries a lower debt/equity ratio of 121% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Aytu BioPharma, Inc.

(AYTU) is pulling ahead at 1. 8% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Aytu BioPharma, Inc. grew EPS 24. 5% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, PRGO leads at -1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Aytu BioPharma, Inc.

(AYTU) is the more profitable company, earning -20. 4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps -20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -11. 8% for AYTU. At the gross margin level — before operating expenses — AYTU leads at 69. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, PRGO (9.

8% yield) pays a dividend. AYTU does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, AYTU: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AYTU is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while AYTU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.